Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized phase 3 trial of arsenic trioxide and/or ATRA during consolidation in newly diagnosed acute promyelocytic leukemia
2005-005397-74Phase 3Terminated
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jan 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of arsenic trioxide, tretinoin in Acute promyelocytic leukaemia (APL), sponsored by Assistance publique - Hôpitaux de Paris. Started Jan 2009; status: terminated.
02
Drugs
arsenic trioxidetretinoin
03
Conditions
Acute promyelocytic leukaemia (APL)
Beyond the preview
Go deeper on 2005-005397-74.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005397-74.